After the completion of the human genomic project, most human-expressed genes have been identified, and full-length cDNA of these genes have become publicly available. In the emerging proteomics era, proteins act as the key players in the unveiling of these genes. In order to effectively decipher the mystery of these proteins, antibodies with their inherent sensitivity and specificity thus become the most versatile tools for providing one-to-one relationship with their target proteins.

The mission of Abnova is to become a leader in high-throughput antibody and protein production. Abnova intends to become the world’s largest protein and antibody catalog company by building a full collection of essential proteins and their antibodies targeting the human genome.